Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 20;36(3):563-565.
doi: 10.1093/ndt/gfaa270.

Serum potassium laboratory reference ranges influence provider treatment behaviors for hyperkalemia

Affiliations

Serum potassium laboratory reference ranges influence provider treatment behaviors for hyperkalemia

Jamie S Hirsch et al. Nephrol Dial Transplant. .
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Changes in SPS ordering patterns based on serum potassium reference upper limit. (A) The initial spike in SPS ordering occurred earlier, at a serum potassium of 5.2 mEq/L, when the reference upper limit was 5.1 mEq/L, whereas it occurred later when the reference upper limit was 5.3 mEq/L. (B) The maximal difference between the two groups occurred at a serum potassium of 5.3 mEq/L, with a 17.5% difference in cumulative distribution between the two groups. Blue rectangle highlights the area that was designated as hyperkalemia with a reference upper limit 5.1 mEq/L, but normokalemia at 5.3 mEq/L. (C) Interrupted time series examining the change in SPS ordering for a serum potassium level of 5.2–5.3 mEq/L. In the first period, with a serum potassium reference upper limit of 5.1 mEq/L, 9.8% of serum potassium results of 5.2–5.3 mEq/L (flagged as abnormal and high) resulted in an SPS order, whereas in the second period (reference upper limit 5.3 mEq/L), SPS was only ordered 0.9% of the time for the same serum potassium results (flagged as normal).

References

    1. Hollander-Rodriguez JC, Calvert JF Jr. Hyperkalemia. Am Fam Physician 2006; 73: 283–290 - PubMed
    1. Einhorn LM, Zhan M, Hsu VD et al. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 2009; 169: 1156–1162 - PMC - PubMed
    1. Montford JR, Linas S. How dangerous is hyperkalemia? J Am Soc Nephrol 2017; 28: 3155–3165 - PMC - PubMed
    1. Mueller ZT, Crannage AJ. Evaluation of appropriate sodium polystyrene sulfonate use with a hyperkalemia order set: a pilot study. J Pharm Pract 2019; 32: 493–498 - PubMed
    1. Hoppe LK, Muhlack DC, Koenig W et al. Association of abnormal serum potassium levels with arrhythmias and cardiovascular mortality: a systematic review and meta-analysis of observational studies. Cardiovasc Drugs Ther 2018; 32: 197–212 - PubMed